Coronavirus / COVID

A discussion on how the pediatric inflammatory syndrome has begun to affect the US months into the pandemic.

Black Americans bear a disproportional burden and negative outcomes from the coronavirus.

A discussion with a Yale expert on what new CDC data shows.

Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.

The purchase by Health and Human Services ensures US hospitals can secure the COVID-19 medication for the next few months.

BNT162b1, a SARS-CoV-2 vaccine candidate, elicited promising early signs of immune activity in a placebo-controlled phase 1/2 study.

A brief overview of our top stories.

Jonathan Spero, MD, discusses workplace safety in the time of SARS-CoV-2.

Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. Are these fears grounded?

With more COVID-19 cases being realized in the US, the White House Coronavirus Task Force testified before the Senate today.

New recommendations are intended to aid biomedical firms in achieving licensure of a safe and effective vaccine.

Judith Feinberg, MD, FIDSA, describes surprising outcomes in many COVID-19 cases among people living with HIV.

In a recent CDC Morbidity and Mortality Weekly Report, data showed greater intensive care unit admission and mechanical ventilation for this group of patients.

A brief overview of our recent coverage.

Opaganib is set to be evaluated against SARS-CoV-2 in a multi-center, randomized, parallel arm, double-blind, placebo-controlled study.

Researchers have found 6 inflammatory molecules in critically ill patients, which might be used as therapeutic targets in fighting COVID-19.

The status of emergency departments in the city during the pandemic's migration west.

Bradley Sherman, MD, shares insight as to what goes into a respiratory ventilator recovery unit.

Four human coronavirus infection rates were relatively consistent among all age groups older than 4 years, the study also found.

A brief summary of the latest news.

A look at how the state became a belated hotspot, and what may help reduce future infection growth.

A group of scientists hypothesize these shots could protect young children from the novel virus.

A European study shows a small amount of hospitalized children and adolescents with COVID-19 require intensive care and is rarely fatal.

A brief on today's top ID news.

The Hong Kong researchers used online searches to quantify public interest in mask usage.

The finger-prick test showed 98.8% specificity for novel coronavirus in assessments including 1500 patients.

Analysis suggests approach may be particularly useful when testing resources are limited.

Where did things go wrong for the Grand Canyon State?

A high proportion of N95 masks failed to fit properly with the extended use and reuse recommended by the CDC for conserving PPE during the shortage.

Video briefing on the day's top infectious disease news.